T1	Procedure 11 39	Interleukin-2 (IL-2) therapy
T2	Temporal 40 69	within 8 weeks of study entry
R1	Has_temporal Arg1:T1 Arg2:T2	
T3	Condition 111 162;88 95	illness that may interfere with study participation medical
T4	Condition 99 162	psychiatric illness that may interfere with study participation
*	OR T3 T4
T5	Condition 164 172	Pregnant
